#healthcare — FinScans

News 📈 Stocks

Comparing IYH and PBE: Choosing the Right Healthcare ETF for Long-Term Growth

September 11, 2026 (60 days ago)

The iShares U.S. Healthcare ETF (IYH) provides a cost-effective, diversified core for portfolios, while the Invesco Biotechnology & Genome ETF (PBE) serves…

IYH LLY PBE +5

🌍 AMERICAS Read More →

News 📈 Stocks

InnovAge Reports 175% EBITDA Growth, Launches Strategic Scaling Phase

September 11, 2026 (60 days ago)

InnovAge posts robust fiscal 2026 results with a 175% jump in adjusted EBITDA, signaling a shift toward aggressive scaling and value-based care…

INNV

🌍 AMERICAS Read More →

News 📈 Stocks

Cigna Executive Neville Everett Sells 617 Shares Valued at $175,259

September 11, 2026 (60 days ago)

Cigna executive Neville Everett offloaded 617 shares in a pre-planned transaction, maintaining a remaining direct stake of 5,053 shares valued at $1.45…

CI

🌍 AMERICAS Read More →

News 📈 Stocks

Jim Cramer Ranks JNJ, LLY, and PFE Amid Healthcare Sector Rotation

September 11, 2026 (60 days ago)

Jim Cramer highlights JNJ as a top-tier defensive pick while signaling a buy for Eli Lilly after its recent dip, contrasting their…

JNJ LLY CAH +1

🌍 AMERICAS Read More →

News 📈 Stocks

Humana Shares Surge 57% YTD as Medicare Advantage Growth Outpaces Dow

September 11, 2026 (61 days ago)

Humana stock maintains strong momentum above its 50-day moving average, supported by robust Medicare Advantage growth, even as the company navigates regulatory…

HUM CNC $DOWI

🌍 AMERICAS Read More →

News 📈 Stocks

Medtronic and MercadoLibre Offer Long-Term Value After Recent Market Lags

September 10, 2026 (61 days ago)

Medtronic and MercadoLibre remain top buy-and-hold candidates as both companies navigate strategic growth initiatives and market headwinds to secure future dominance.

MELI

🌍 NORTH AMER Read More →

News 📈 Stocks

IHE vs. RSPH: Comparing 2026 Healthcare ETF Performance and Strategy

September 10, 2026 (61 days ago)

IHE outperforms RSPH in recent 1-year returns and lower drawdown, making it a preferred choice for investors seeking concentrated pharmaceutical exposure over…

JNJ NVDA NFLX

🌍 NORTH AMER Read More →

News 📈 Stocks

Teladoc and Recursion Pharmaceuticals Face Dim Outlooks Amid Growth Struggles

September 10, 2026 (61 days ago)

Investors should avoid Teladoc and Recursion Pharmaceuticals as both companies grapple with declining revenue, stiff competition, and unproven business models in a…

LLY NVO BMY

🌍 NORTH AMER Read More →

News 📈 Stocks

Comparing IHE and IYH: Choosing the Best Healthcare ETF for 2026

September 10, 2026 (61 days ago)

BlackRock's IHE and IYH offer distinct paths for healthcare exposure, with IHE's concentrated pharmaceutical focus currently outperforming the broader, more diversified IYH…

LLY JNJ ABBV +2

🌍 NORTH AMER Read More →

News 📈 Stocks

JNJ and ABBV Offer Defensive Dividend Yields Amid Market Volatility

September 9, 2026 (62 days ago)

Healthcare giants Johnson & Johnson and AbbVie provide defensive income streams and consistent dividend growth, offering investors a hedge against broader market…

JNJ ABBV

🌍 NORTH AMER Read More →

News 📈 Stocks

Welltower Shares Surge 41% Annually as Senior Housing Demand Drives Growth

September 9, 2026 (62 days ago)

Welltower shares climb 40.9% annually, fueled by strong senior housing demand and a 25% jump in Q2 FFO, leaving the Nasdaq Composite's…

WELL

🌍 NORTH AMER Read More →

News 📈 Stocks

Zoetis Shares Slump 50% Annually as Earnings Guidance Faces Downward Revision

September 8, 2026 (63 days ago)

Zoetis shares continue to struggle, down over 50% in the past year, as the company grapples with safety perception headwinds for its…

ZTS

🌍 NORTH AMER Read More →